Stockscreener 앱 받기
62.61
1.26%
-0.8004
시간 외 거래:
62.61
전일 마감가:
$63.41
열려 있는:
$62.77
하루 거래량:
3,420
Relative Volume:
0.43
시가총액:
$281.93M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+1.43%
1개월 성능:
+1.46%
6개월 성능:
-11.19%
1년 성능:
-0.22%
1일 변동 폭
$62.25
$62.85
1주일 범위
$62.25
$63.47
52주 변동 폭
$54.52
$72.84
Invesco Biotechnology Genome Etf Stock (PBE) Company Profile
PBE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PBE
Invesco Biotechnology Genome Etf
|
62.61 | 281.93M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
289.88 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
589.39 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
592.15 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
228.19 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
519.11 | 124.43B | 0 | 0 | 0 | 0.00 |
Invesco Biotechnology Genome Etf 주식(PBE)의 최신 뉴스
Bank of America Corp DE Has $4.59 Million Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - sharewise
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Stake Lessened by Cetera Investment Advisers - Defense World
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Yahoo Finance
Stifel Financial Corp Acquires 16,892 Shares of RiverNorth Managed Duration Municipal Income Fund II, Inc. (NYSEARCA:RMMZ) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Sold by Tower Research Capital LLC TRC - Defense World
Stifel Financial Corp Sells 600 Shares of SRH Total Return Fund, Inc. (NYSE:STEW) - Defense World
Stifel Financial Corp Sells 1,457 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Stifel Financial Corp Grows Stock Holdings in Schwab U.S. REIT ETF (NYSEARCA:SCHH) - Defense World
Susquehanna International Group LLP Makes New Investment in VictoryShares Core Intermediate Bond ETF (NASDAQ:UITB) - Defense World
Stifel Financial Corp Acquires 5,291 Shares of T. Rowe Price Dividend Growth ETF (NYSEARCA:TDVG) - Defense World
Hsbc Holdings PLC Grows Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Hsbc Holdings PLC Purchases 16,554 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
Barclays PLC Buys 10,174 Shares of FT Vest U.S. Equity Enhance & Moderate Buffer ETF – January (NYSEARCA:XJAN) - Defense World
16,974 Shares in VNET Group, Inc. (NASDAQ:VNET) Bought by Tower Research Capital LLC TRC - Defense World
Tower Research Capital LLC TRC Lowers Position in The Marcus Co. (NYSE:MCS) - Defense World
Hsbc Holdings PLC Has $232,000 Stock Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World
Hsbc Holdings PLC Takes Position in Vir Biotechnology, Inc. (NASDAQ:VIR) - Defense World
Tower Research Capital LLC TRC Has $71,000 Holdings in CTO Realty Growth, Inc. (NYSE:CTO) - Defense World
Dimensional Fund Advisors LP Raises Stake in REGENXBIO Inc. (NASDAQ:RGNX) - Defense World
Dimensional Fund Advisors LP Raises Holdings in Blue Foundry Bancorp (NASDAQ:BLFY) - Defense World
Klaviyo, Inc. (NYSE:KVYO) Shares Bought by Tower Research Capital LLC TRC - Defense World
LENZ Therapeutics’ (LENZ) “Buy” Rating Reiterated at HC Wainwright - Defense World
Gladstone Commercial Co. (NASDAQ:GOOD) Stake Raised by Dimensional Fund Advisors LP - Defense World
Hsbc Holdings PLC Makes New Investment in Customers Bancorp, Inc. (NYSE:CUBI) - Defense World
Stifel Nicolaus Issues Pessimistic Forecast for Russel Metals (TSE:RUS) Stock Price - Defense World
(PBE) Investment Analysis - news.stocktradersdaily.com
Biotech Outperformance: Can’t Take What’s Already Earned - Seeking Alpha
Diamond Hill Investment Group, Inc. (NASDAQ:DHIL) Shares Sold by First Trust Advisors LP - Defense World
Marshall Wace LLP Purchases Shares of 38,500 908 Devices Inc. (NASDAQ:MASS) - Defense World
Raymond James Financial Inc. Purchases New Shares in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Stock Holdings Lowered by LPL Financial LLC - Defense World
Envestnet Asset Management Inc. Raises Stake in Invesco S&P 500 Equal Weight Materials ETF (NYSEARCA:RSPM) - Defense World
Envestnet Asset Management Inc. Invests $1.41 Million in Atour Lifestyle Holdings Limited (NASDAQ:ATAT) - Defense World
T. Rowe Price Ultra Short-Term Bond ETF (NYSEARCA:TBUX) Shares Sold by Envestnet Asset Management Inc. - Defense World
BlackRock Municipal Income Trust II (NYSE:BLE) Shares Acquired by Invesco Ltd. - Defense World
Wells Fargo & Company MN Acquires 4,396 Shares of Peoples Bancorp Inc. (NASDAQ:PEBO) - Defense World
Russell Investments Group Ltd. Grows Holdings in Capricor Therapeutics Inc (NASDAQ:CAPR) - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Bought by Russell Investments Group Ltd. - Defense World
Bank of Montreal Can Cuts Stock Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Invesco S&P SmallCap Information Technology ETF (NASDAQ:PSCT) Shares Sold by Wells Fargo & Company MN - Defense World
Wells Fargo & Company MN Decreases Stake in Invesco Trust for Investment Grade Municipals (NYSE:VGM) - Defense World
Wells Fargo & Company MN Decreases Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Eli Lilly and Co (NYSE:LLY): Promising Breakthrough in Weight-Loss Treatments - Value The Markets
When (PBE) Moves Investors should Listen - news.stocktradersdaily.com
LPL Financial LLC Increases Position in ProShares Nasdaq-100 High Income ETF (NASDAQ:IQQQ) - Defense World
LPL Financial LLC Boosts Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Raymond James Financial Inc. Purchases Shares of 18,878 Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Raymond James Financial Inc. Takes Position in PIMCO Municipal Income Fund III (NYSE:PMX) - Defense World
Commonwealth Equity Services LLC Has $1.73 Million Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Biotech stocks and ETFs at a potential turning point - Fidelity
Invesco Biotechnology Genome Etf (PBE) 재무 분석
Invesco Biotechnology Genome Etf (PBE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.16%
0.09%
자본화:
|
볼륨(24시간):